Pasithea Therapeutics (KTTA) Times Interest Earned (2021 - 2026)

Pasithea Therapeutics has reported Times Interest Earned for 6 years, with the latest figure at -$7.74 in Q1 2026.

• Quarterly Times Interest Earned fell 165.02% year-over-year to -$7.74 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$35.0 (down 217.56% YoY) and the FY2025 annual result came in at -$0.02, up 99.99% from the prior year.
• Times Interest Earned advanced to -$7.74 in Q1 2026 per KTTA's latest filing, from -$131.85 in the prior quarter.
• Over five years, Times Interest Earned peaked at -$1.59 in Q3 2024 and troughed at -$323.62 in Q4 2022.
• A 5-year average of -$42.38 and a median of -$6.06 in 2023 frame the typical range for Times Interest Earned.
• The sharpest annual moves came in 2022 and 2024: Times Interest Earned slumped 15301.49% in 2022, then soared 73.57% in 2024.
• Over 5 years, Times Interest Earned stood at -$323.62 in 2022, then jumped by 98.14% to -$6.01 in 2023, then surged by 73.57% to -$1.59 in 2024, then plunged by 8195.84% to -$131.85 in 2025, then surged by 94.13% to -$7.74 in 2026.
• According to Business Quant data, Times Interest Earned over the past three periods registered -$7.74, -$131.85, and -$4.94 for Q1 2026, Q4 2025, and Q3 2025 respectively.